Factor V Leiden

MASTER FM EOR

MASTER FM EOR

Aortic valve disease
Mitral valve disease
Pulmonary valve disease
Tricuspid valve disease
Lung cancer
Sleep apnea
Diarrhea: Clinical
Rotavirus
Norovirus
Escherichia coli
Salmonella (non-typhoidal)
Salmonella typhi (typhoid fever)
Vibrio cholerae (Cholera)
Ventricular septal defect
Hypertrophic cardiomyopathy
Shigella
Gastroenteritis
Ulcerative colitis
Crohn disease
Hyperlipidemia
Heart failure
Chronic bronchitis
Irritable bowel syndrome
Emphysema
Aphthous ulcers
Meniere disease
Dizziness and vertigo: Clinical
Parotitis
Acute cholecystitis
Chronic cholecystitis
Gallstones
Gallstone ileus
Colorectal polyps
Colorectal cancer
Labyrinthitis
Breast cancer
Cervical cancer
Conjunctivitis
Diabetic retinopathy
Hypertensive emergency
Fibromyalgia
Gastritis
Skin cancer
Contact dermatitis
Atopic dermatitis
Seborrhoeic dermatitis
Human herpesvirus 8 (Kaposi sarcoma)
Eczematous rashes: Clinical
Lichen planus
Menopause
Spinal disc herniation
Lower back pain: Clinical
Bursitis
Osteoporosis
Age-related macular degeneration
Reactive arthritis
Stevens-Johnson syndrome
Hemorrhoid
Peptic ulcer
Mallory-Weiss syndrome
Gastrointestinal bleeding: Clinical
Diverticulosis and diverticulitis
Boerhaave syndrome
Anal fissure
Esophageal cancer
Esophagitis: Clinical
Portal hypertension
Pregnancy
Contraception: Clinical
Otitis media
Otitis externa
Poststreptococcal glomerulonephritis
Membranoproliferative glomerulonephritis
Alport syndrome
IgA nephropathy (NORD)
Rapidly progressive glomerulonephritis
Testicular cancer
Membranous nephropathy
Focal segmental glomerulosclerosis (NORD)
Minimal change disease
Rosacea
Psoriasis
Erythema multiforme
Sleep disorders: Clinical
Peripheral artery disease
Peripheral vascular disease: Clinical
Mycobacterium tuberculosis (Tuberculosis)
Cirrhosis
Cushing syndrome
Primary adrenal insufficiency
Retinal detachment
Sialadenitis
Eye conditions: Retinal disorders: Pathology review
Acute pancreatitis
Chronic pancreatitis
Actinic keratosis
Bullous pemphigoid
Alopecia: Clinical
Abnormal uterine bleeding: Clinical
Systemic lupus erythematosus (SLE): Clinical
Systemic lupus erythematosus
Benign prostatic hyperplasia
Epididymitis
Prostatitis
Neisseria gonorrhoeae
Chlamydia trachomatis
Urethritis
Erysipelas
Parvovirus B19
Measles virus
Human herpesvirus 6 (Roseola)
Pediatric infectious rashes: Clinical
Iron deficiency anemia
Anemia of chronic disease
Aplastic anemia
Folate (Vitamin B9) deficiency
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Autoimmune hemolytic anemia
Sickle cell disease (NORD)
Alpha-thalassemia
Beta-thalassemia
Vitamin B12 deficiency
Atrial fibrillation
Atrioventricular nodal reentrant tachycardia (AVNRT)
Ventricular tachycardia
Atrial flutter
Atrioventricular block
Bundle branch block
Premature atrial contraction
Premature ventricular contraction
Long QT syndrome and Torsade de pointes
Ventricular fibrillation
Wolff-Parkinson-White syndrome
Gastroesophageal reflux disease (GERD)
Vulvovaginitis: Clinical
Pelvic inflammatory disease
Acne vulgaris
Cellulitis
Folliculitis
Pressure ulcer
Gardnerella vaginalis (Bacterial vaginosis)
Candida
Trichomonas vaginalis
Impetigo
Human papillomavirus
Bites and stings: Clinical
Angina pectoris
Stable angina
Unstable angina
Prinzmetal angina
Coronary artery disease: Clinical
Hypertension: Clinical
Allergic rhinitis
Glaucoma
Streptococcus pyogenes (Group A Strep)
Borrelia burgdorferi (Lyme disease)
Asthma
Gout
Nasal polyps
Pneumonia
Pneumonia: Clinical
Bowel obstruction
Bowel obstruction: Clinical
Volvulus
Intussusception
Retropharyngeal and peritonsillar abscesses
Hordeolum (stye)
Osteoarthritis
Rheumatoid arthritis
Rheumatoid arthritis: Clinical
Sarcoptes scabiei (Scabies)
Alzheimer disease
Vascular dementia
Frontotemporal dementia
Parkinson disease
Lewy body dementia
Huntington disease
Headaches: Clinical
Migraine
Cluster headache
Tension headache
Bell palsy
Orthostatic hypotension
Hyperthyroidism
Seizures: Clinical
Epilepsy
Transient ischemic attack
Delirium
Dementia and delirium: Clinical
Onychomycosis
Pityriasis rosea
Vertigo
Hypothyroidism
Pericarditis and pericardial effusion
Aortic dissection
Pulmonary embolism
Pulmonary hypertension
Myocarditis
Acute leukemia
Chronic leukemia
Von Willebrand disease
Hemophilia
HIV (AIDS)
Meningitis
Hodgkin lymphoma
Non-Hodgkin lymphoma
Immune thrombocytopenia
Thrombotic thrombocytopenic purpura
Disseminated intravascular coagulation
Hemolytic-uremic syndrome
Polycythemia vera (NORD)
Hernias: Clinical
Abdominal hernias
Lower urinary tract infection
Orchitis
Acute pyelonephritis
Kidney stones
Appendicitis
Anorexia nervosa
Generalized anxiety disorder
Panic disorder
Anxiety disorders: Clinical
Bipolar and related disorders
Bulimia nervosa
Major depressive disorder
Child abuse: Clinical
Alcohol use disorder
Cannabis dependence
Opioid dependence
Cocaine dependence
Tobacco dependence
Anaphylaxis
Burns
Burns: Clinical
Bites and stings: Clinical
Orbital cellulitis
Acute respiratory distress syndrome
Placental abruption
Placenta previa
Hypertension
Pneumothorax
Pneumothorax: Clinical
Post-traumatic stress disorder
Phobias
Neuroleptic malignant syndrome
Factor V Leiden
Protein C deficiency
Protein S deficiency
Salmonellosis
Syncope: Clinical

Transcript

Watch video only

Factor V Leiden is a disorder where blood clots form more easily due to a mutation in a clotting protein called factor V. Factor V Leiden is the most common hypercoagulable disorder in people of caucasian descent, and was named after the town Leiden in Holland, where the disease was first described.

Now, Factor V Leiden is a hemostasis disorder.

Hemostasis is the process where blood flow is stopped after there’s damage to a blood vessel, and it has two steps.

Primary hemostasis involves the formation of a platelet plug at the site of injury, and secondary hemostasis involves the coagulation cascade, where several clotting factors come into play to form a fibrin mesh over the platelet plug to reinforce it - forming a blood clot.

Hemostasis can be both stimulated, and inhibited by several factors.

One way to stimulate hemostasis is with thrombin, or factor II, which increases platelet activation, and cleaves several factors involved in secondary hemostasis to their active form.

So one way to inhibit hemostasis is actually to inhibit thrombin.

This happens with the help of anticoagulant proteins like protein C. Protein C is a vitamin K dependent circulating plasma protein produced in the liver along with a cofactor called protein S.

Both protein C and S interact with a protein called thrombomodulin, which is on the surface of intact endothelial cells that line our blood vessels.

So, let’s say you cut your finger and now a blood clot has formed.

When there’s a lot of thrombin around a damaged blood vessel, excess thrombin binds to thrombomodulin and it can no longer participate in the coagulation cascade.

So in a sense, the undamaged cells help ensure that the coagulation process is limited to the injury site.

Furthermore, the thrombin-thrombomodulin complex binds to protein C. Protein S then joins the party, forming a complex that includes protein C, protein S, and thrombin-thrombomodulin. Protein S binding to this complex activates the proteolytic site of protein C which then cleaves and inactivates active factor V, which is a cofactor for factor X in the common pathway of the coagulation cascade, as well as factor VIII, which is a cofactor for factor IX in the intrinsic pathway of the coagulation cascade.

This slows down coagulation. What is more, the factor V degradation product also binds to this complex and further enhances its ability to cleave more active factor V and active factor VIII, further limiting coagulation.

So anticoagulation prevents clots from growing too large and blocking blood flow to tissues supplied by the vessel.

It also prevents clots from getting so big that small parts of the growing clot break off in the form of emboli.

So with Factor V Leiden, both active factor V, termed Va and inactivated factor V become resistant to cleavage by activated protein C because of a mutation that results in a misshapen cleavage site.

So when activated protein C, protein S, and the thrombin-thrombomodulin complex binds and tries to cleave factor Va or inactivate factor V, it can't because the normal cleavage site isn’t there!

And when factor V can’t be inactivated, you guessed it - coagulation doesn’t slow down, so there’s increased blood clot formation.

Usually, these clots develop in the deep veins of the lower limbs, like the popliteal and femoral veins, causing a venous thromboembolism, where small parts of the clot can break off and travel to other organs, like the lungs, the brain or the liver, cutting off blood flow to those organs.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  3. "Harrison's Principles of Internal Medicine" McGraw-Hill (2004)
  4. "Factor V Leiden" Radiol Technol (2019)
  5. "Factor V Leiden thrombophilia" Genet Med (2011)
  6. "Factor V Leiden" The Journal of Perinatal & Neonatal Nursing (2003)
  7. "Diagnosis and management of<i>factor V Leiden</i>" Expert Review of Hematology (2016)